Purpose: Obesity appears to play a role in the development of knee osteoarthritis (OA) and has been shown to influence pain and disease progression. Leptin is an adipokine involved in body weight regulation and known to show inflammatory effects in high concentrations and has also been implicated in OA physiopathology and pain. Objective: To evaluate the correlation between different body weight measurements (body mass index (BMI), waist-to-hip ratio (WTHr) and percentage of body fat (PBF)) and synovial fluid leptin and a surrogate marker of inflammation such as the amount of synovial fluid. Methods: Patients aged 50 years or more with symptomatic knee OA and joint effusion, Kellgren-Lawrence II-III. Demographics, disease duration and body mass index (BMI), waist-to-hip radio (WTHr) and percentage of body fat (PBF) were assessed. Percentage of body fat was determined by bio-electrical impedance. Knee ultrasound (US) was performed evaluating and measuring the presence of effusion and at the suprapatellar midline. After US measurement joint aspiration was performed; all patients were evaluated approximately at the same time of the day. Synovial leptin levels were analyzed using a Human leptin ELISA kit (Biocompare, California, USA). Results: Seventy consecutive female patients with symptomatic knee OA and Kellgren-Lawrence II-III were included, age 65 ±7.8 (50-79) years, disease duration of symptoms 66 ±49.5 mo (12-200). Mean BMI was 31.5 ±5.1 kg, mean WTHr 0.94 ±0.082 and mean BFP 42.34 ±5.11%. Mean synovial fluid measurement was 9.59 ±2.79 mm. Mean levels of leptin in synovial fluid were 76.76 ±38.66 ng/mL. None of the different types of body weight measurement showed any correlation with the amount of synovial fluid on US. On the other hand BMI and BFP showed similar moderate positive correlation with synovial fluid levels of leptin (r¼ 0.4626 and r¼ 0.4610, respectively), whereas no correlation was found between WTHr and leptin synovial levels (r¼ 0.059). Conclusions: Both BMI and the percentage of body fat were moderately correlated with synovial levels of leptin in a similar degree. Thus, synovial leptin may be associated in a similar way with a measure of relative weight as BMI or with a measure reflecting relative fat content. On the contrary, severity of obesity did not appear to correlate with a marker of inflammation such as synovial effusion.
Purpose: Obesity appears to play a role in the development of knee osteoarthritis (OA) and has been shown to influence pain and disease progression. Leptin is an adipokine involved in body weight regulation and known to show inflammatory effects in high concentrations and has also been implicated in OA physiopathology and pain. Objective: To evaluate the correlation between different body weight measurements (body mass index (BMI), waist-to-hip ratio (WTHr) and percentage of body fat (PBF)) and synovial fluid leptin and a surrogate marker of inflammation such as the amount of synovial fluid. Methods: Patients aged 50 years or more with symptomatic knee OA and joint effusion, Kellgren-Lawrence II-III. Demographics, disease duration and body mass index (BMI), waist-to-hip radio (WTHr) and percentage of body fat (PBF) were assessed. Percentage of body fat was determined by bio-electrical impedance. Knee ultrasound (US) was performed evaluating and measuring the presence of effusion and at the suprapatellar midline. After US measurement joint aspiration was performed; all patients were evaluated approximately at the same time of the day. Synovial leptin levels were analyzed using a Human leptin ELISA kit (Biocompare, California, USA). Results: Seventy consecutive female patients with symptomatic knee OA and Kellgren-Lawrence II-III were included, age 65 ±7.8 (50-79) years, disease duration of symptoms 66 ±49.5 mo (12-200). Mean BMI was 31.5 ±5.1 kg, mean WTHr 0.94 ±0.082 and mean BFP 42.34 ±5.11%. Mean synovial fluid measurement was 9.59 ±2.79 mm. Mean levels of leptin in synovial fluid were 76.76 ±38.66 ng/mL. None of the different types of body weight measurement showed any correlation with the amount of synovial fluid on US. On the other hand BMI and BFP showed similar moderate positive correlation with synovial fluid levels of leptin (r¼ 0.4626 and r¼ 0.4610, respectively), whereas no correlation was found between WTHr and leptin synovial levels (r¼ 0.059). Conclusions: Both BMI and the percentage of body fat were moderately correlated with synovial levels of leptin in a similar degree. Thus, synovial leptin may be associated in a similar way with a measure of relative weight as BMI or with a measure reflecting relative fat content. On the contrary, severity of obesity did not appear to correlate with a marker of inflammation such as synovial effusion. Purpose: For prevention of osteoarthritis (OA) or early intervention of OA we need specific clinical signs and symptoms that predict patellafemoral (PF) or tibio-femoral (TF) OA. In an earlier study we found that crepitus and history of patellar pain indicated lesions in the PF-joint seen at MRI, and that these signs were not indicative for TF joint lesions. These results were based on cross-sectional data and follow-up data needs to confirm if these tests have an additional diagnostic value for early knee OA in the PF-or TF compartment. In addition some other clinical signs and symptoms might be predictive for the TFOA. Therefore in the present study we investigate if promising signs and symptoms seen at baseline are predictive for getting OA in PF or TF after 5 years. Methods: Of the first subsample (n¼337) of the 891 females (aged 45-60) from the nested cohort of the Rotterdam Study, baseline and 5-years follow-up MRIs of both knees were assessed for knee OA with the MRI Osteoarthritis Knee Score (MOAKS). Based on these scored features we applied the proposed MRI definition. We distinguished the PFOAMRIdefinition from the TFOAMRI-definition. At the baseline clinical signs and symptoms were tested side specific in a physical examination. Crepitus was tested and defined as a hearable grinding noise and/or palpable vibrations in the knee, detected by the hand of the investigator rested on the patella of the participant during active flexion or extension of the knee. Joint line tenderness was examined. Current knee pain, knee pain in the last year, knee pain on most days of the last month, knee pain for 4 days or more a week or severe enough to consult a general practitioner, history of patellar knee pain and the feeling of giving way were reported site specific by the participants in a questionnaire at baseline. Binomial logistic generalized estimated equations were used to determine the predictive value between the baseline clinical findings and PFOAMRI or TFOAMRI at follow-up. All knees of the participants with PF-or TFOAMRI at baseline were excluded from analysis. All associations were adjusted for age, body mass index (BMI), and the other clinical features. In the analysis for PFOAMRI we adjusted additionally for TFOAMRI and vice versa. Results: Of the first 337 women of whom MRIs are scored 566 knees of 291 women have no OA at baseline (16 women are in the analysis with just one knee). At baseline mean age is 54.9 years (sd¼3.9) and mean BMI is 26.8 kg/m 2 (sd¼4.3). Mean follow-up time is 5.1 years (sd¼0.4). Of these 566 knees 27 knees (4.8%) have PFOA:MRI and 35 knees (6.2%) have TFOAMRI at follow up. Crepitus is predictive for PFOA and not for TFOA. The post-test predictive value of getting PFOAMRI in 5 years doubled to 9.1%. Joint line tenderness and the feeling of giving way were predictive for having TFOAMRI at follow-up. The post-test predictive value of joint line tenderness more than tripled to 23.3%. The predictive value of the feeling of giving way tripled as well to 18.5%. When combining these two symptoms the post-test predictive value for having TFOA at 5 year follow-up was more than fivefold the pre-test predictive value (35.7%). History of patellar pain, knee pain at baseline defined as 'having current knee pain (yes/no)', 'having had knee pain in the last year (yes/no)', 'having had knee pain for most days of the last month (yes/no)', or 'having knee pain for 4 days or more a week or severe enough to consult a general practitioner (yes/no)' did not predict PFOAMRI nor TFOAMRI adjusted for crepitus with PFOAMRI and joint line tenderness and the feeling of giving way for TFOAMRI. Conclusions: Crepitus is an early sign of PFOAMRI. Joint line tenderness and the feeling of giving way are symptoms of TFOAMRI. The posttest predictive value of joint line tenderness and the feeling of giving way together is more than fivefold the pretest predictive value for TFOAMRI at five year. Knee pain is not an early symptom of PF-or TFOAMRI. These result will be validated in the second subsample of our study population. Purpose: Knee osteoarthritis (knee OA) is a disease in which the structure of the knee gradually degenerates and knee pain and deformity occur. Changes in lower extremity alignment affect the progression of the condition, and many patients present knee varus deformity or limited knee extension. Limited knee extension is said to cause posterior pelvic tilt or decreased lumbar lordosis, and it may be that in cases of knee OA changes occur in spinal alignment in addition to lower extremity alignment. However, few studies have analyzed the Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A330
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